在先进的侵袭性皮上腺癌中,对米托坦单一疗法的异常反应
Maria Elena Aloini1, Pina Lardo1, Roberta Maggio1
1Department of Endocrinology, Department of Clinical and Molecular Medicine, Sant'Andrea University Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome 00189, Italy.
先进的上腺皮层癌 (ACC) 是具有侵略性的. 一位患有转移性ACC的患者对米托坦单一治疗反应良好,即使血水平较低,也表明治疗潜力更广泛.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 皮上腺癌 (ACC) 是一种罕见且具有侵略性的内分泌瘤,晚期预后不佳.
- 目前先进的ACC的第一线治疗包括单独或与化疗一起的米托坦,单独治疗的响应率有限.
更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
相关概念视频
Treatment Resistant Cancers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
